INTRODUCTION
The Ca' ion plays a crucial role as a second messenger in various biological events [1] . Evidence has been accumulating which suggests that many of the physiological functions of Ca2" may be mediated by Ca2+-receptor proteins such as calmodulin (CaM) . CaM indeed activates a number of enzymes in a Ca2+-dependent manner [2] , including a cyclic nucleotide phosphodiesterase (CaM-PDE; [3] [4] . These socalled CaM antagonists share an amphiphilic (hydrophobic plus cationic) character and interact with some acidic phospholipids and fatty acids. It has been demonstrated for several CaM-dependent enzymes that unsaturated fatty acids, acidic phospholipids and limited proteolysis mimic the effect of CaM [5] [6] [7] [8] . It is of interest also that some so-called CaM antagonists inhibit the activation of phosphodiesterase induced by various types of activators other than CaM [9] [10] [11] . It appears probable that anionic amphiphile-activated phosphodiesterase may be inhibited by complexation of the activator with the inhibitor via ionic and hydrophobic interactions and for proteolysis-activated enzyme by direct interaction of the inhibi-tor with the enzyme [9] . Moreover, many socalled CaM antagonists, if not all, also inhibit protein kinase C through a competitive interaction with acidic phospholipid cofactor [12] [13] [14] . K-252a, a novel indole carbazol compound isolated from the culture broths of Nocardiopsis sp. [15] and Actinomadula sp. [16] , has proven to be a potent inhibitor of protein kinase. K-252a inhibits several protein kinases, including protein kinase C, cyclic nucleotide-dependent protein kinases and myosin-light-chain kinase competitively with respect to ATP with K, values of about 20nM [17, 18] . Moreover, micromolar amounts of K252a, which is a concentration two orders of magnitude higher than that required for the kinase inhibition, has also been shown to inhibit CaM-PDE with an IC50
(concentration that produces 5000 inhibition of the maximally stimulated activity) value of 2.8 ,UM [15] . Unlike so-called CaM antagonists, a significant feature of K-252a is its neutral character. Therefore, we were interested in exploring the mechanism by which K-252a inhibits CaM-PDE.
were further purified by using CaM-Sepharose 4B to obtain CaM-deficient CaM-PDE and CaM-PDEdeficient CaM [21] . Purity was judged by SDS/polyacrylamide-gel electrophoresis according to the method of Laemmli [22] .
Phosphodiesterase activity was determined at 37°C as described previously [23] using the method of Butcher & Sutherland [24] . This procedure involved coupling of the phosphodiesterase reaction with the 5'-nucleotidase reaction and measuring the Pi liberated within 30 min. The assay medium contained 80 nM-imidazole/HCl buffer, pH 6.9, 3 mM-MgSO4, 0.3 mM-dithiothreitol, 100 mMNaCl, 1.2 mM-cyclic AMP, and either 50 1M-CaCl2 plus 4 units of CaM/ml or 3 mM-EGTA.
Na+ + K+-ATPase was assayed according to the method of Huang et al. [25] .
[3H]Nitrendipine-receptorbinding assay with rat brain membrane was performed basically as described by Gould et al. [26] .
CaM-PDE was treated with 0.05 mg of trypsin/mg of protein at 30°C for 12 min, after which the reaction was terminated by addition of a 22-fold molar excess of soyabean trypsin inhibitor. The activity of the trypsin-treated enzyme prepared by this procedure was essentially identi- cal with the value obtained with CaM and was not further increased by CaM. Sodium oleate (1 mM) also stimulated the enzyme activity up to 650 of the CaMdependent activation. Phosphatidylserine microdispersions were prepared by sonication in a Branson Sonifier B22 for 20 s in 80 mmimidazole/HCl buffer, pH 6.9.
A methanol solution of K-252a (2 mM) was prepared freshly and was diluted with water just before use. The final concentration of methanol was < 0.1 % (v/v), a concentration that had no effect on phosphodiesterase activity. Methanol at a similar concentration was used in the control.
Protein was determined by the method of Bradford [27] , with bovine serum albumin as a standard. The IC50 was determined using six concentrations of each inhibitor and expressed as the mean value of three replicate experiments using one batch of enzyme.
RESULTS
Bovine brain CaM-PDE could be maximally activated 7-13-fold by CaM in the absence of inhibitory drugs. The effect of K-252a on the activation of bovine brain CaM-PDE induced by CaM, limited proteolysis or sodium oleate (1 mM) is shown in Fig. 1 K-252a. Fig. 2 shows the kinetic analysis of K-252a-induced inhibition of CaM-activated phosphodiesterase by means of Dixon plots [28] . The data are compatible with the interpretation that K-252a inhibited CaM-PDE in a competitive manner with respect to CaM; K1 value for K-252a was 1.5,UM. However, increasing [Ca2"] showed no effect on K-252a-induced inhibition of CaMactivated phosphodiesterase (results not shown).
We next examined the effect of varying the amount of cyclic AMP on the trypsin-activated CaM-PDE, which had lost its sensitivity to CaM. Fig. 3 shows the kinetic analysis of K-252a-induced inhibition of trypsin-activated CaM-PDE by means of a double-reciprocal plot. As can be seen from this plot, the inhibition by K-252a of the trypsin-activated enzyme was competitive with respect to cyclic AMP, suggesting that the binding site for K-252a on the enzyme may be closely related to the active centre; K1 value for K-252a was estimated to be 1.7 #UM from secondary plots. Taken together the results suggest that K-252a inhibits the CaM-induced activation of CaM-PDE by interfering directly with the enzyme as well as by CaM antagonism.
To investigate whether or not K-252a interacts with anionic amphiphiles, a smaller amount of either phosphatidylserine (100 ,ug/ml) or sodium oleate (15.6,M) was added to the reaction medium. At these concentrations phosphatidylserine and sodium oleate showed no effect on the phosphodiesterase activity seen in the absence of K-252a. Since K-252a is a neutral compound, unlike so-called CaM antagonists, no interaction of K252a with these anionic amphiles was expected. Indeed, as shown in Fig. 4 , phosphatidylserine and sodium oleate had no effect on the inhibition by K-252a of CaM-PDE but, in contrast, attenuated the inhibition by W-7, compound 48/80 or calmidazolium, which share cationic amphiphilic properties. This implies that K-252a, unlike so-called CaM antagonists, does not interact with phosphatidylserine and sodium oleate. Therefore, it is suf- Table 1 . Effects of various drugs on CaM-dependent and CaM-independent systems Bovine brain CaM-PDE (26 munits/ml) activity and bovine heart CaM-PDE (40 munits/ml) activity were assayed in the presence of 4 units and 2.5 units/ml of CaM, respectively, with 50 guM-CaCl2. The basal activity of bovine brain CaM-PDE (18.6 munits/ml) and bovine heart CaM-independent PDE activity (25 munits/ml) were assayed in the presence of 3 mM-EGTA, but without CaM and CaCI2. Trypsin-activated enzyme (26 munits/ml) and sodium oleate (1 mM)-activated enzyme (26 munits/ml) activities were assayed in the absence of CaM and CaC12. For ficient to understand that the inhibition of sodium oleate-activated CaM-PDE by K-252a, which is shown in Fig. 1 , was brought about by direct interaction of K252a with the enzyme, but not by interaction with sodium oleate. Table 1 summarizes the effects of K-252a, W-7, compound 48/80 and calmidazolium on several CaMdependent and -independent systems. K-252a inhibited bovine heart and brain CaM-PDE to a similar degree. However, inhibition of bovine heart CaM-independent PDE required considerably higher concentrations of K252a. So-called CaM antagonists, such as W-7, compound 48/80 and calmidazolium, inhibited the bovine brain CaM-dependent fraction of the CaM-PDE activity without suppression of its basal activity. The IC50 values were in the same range as those reported previously for anti-CaM [4] . These compounds also inhibited bovine heart and brain CaM-PDE to a similar degree, but showed a lower inhibitory effect on bovine heart CaMindependent PDE. So-called CaM antagonists affected neither trypsin-activated CaM-PDE nor sodium oleateactivated CaM-PDE under the present assay conditions. Because some CaM antagonists had been shown to inhibit [3H]nitrendipine receptor binding [29] and CaMindependent Na' + K+-ATPase [30] , we examined the effect of the drugs tested in the present study on these two CaM-independent systems. K-252a inhibited neither
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DISCUSSION
K-252a inhibits protein kinases at nanomolar concentrations by competing for ATP in a rather non-specific way [17, 18] , whereas it inhibits CaM-PDE at micromolar concentrations [15] . The data in this paper clearly show that K-252a, under the present conditions, does not inhibit CaM-PDE solely by CaM antagonism, but may also interfere directly with the enzyme. Moreover, the binding site on the enzyme is at, or near to, the active centre, since K-252a inhibited trypsin-activated phosphodiesterase in a competitive manner with respect to cyclic AMP.
There have been several papers on the direct interaction of CaM antagonists with CaM-regulated enzymes. Itoh & Hidaka [11] showed that trypsin-treated CaM-PDE was inhibited by various CaM antagonists, such as trifluoperazine, chlorpromazine and a series of W-7 analogues. Furthermore, penfluridol, calmidazolium and trifluoperazine seem to bind, as well as CaM, to erythrocyte Ca2+ + Mg2+-ATPase, a CaM-regulated enzyme, since activation by both tryptic digestion and CaM can be completely inhibited in a similar concentration range [9, 10] . More recently, Xu et al. [31] reported that a derivative of bisbenzylisoquinoline also inhibited trypsinactivated Ca2"+ Mg2+-ATPase at concentrations similar to those that inhibit the activation by CaM. These results suggest that there are binding sites for CaM antagonists on trypsin-activated CaM-regulated enzymes which have similar features to those on CaM.
Although K-252a inhibits CaM-PDE in a competitive manner with respect to CaM, the precise mechanism for this CaM antagonism is still a matter of speculation and study. There are two possible mechanisms that might explain how K-252a could competitively inhibit the CaM-induced activation of CaM-PDE. K-252a could either interact directly with CaM itself or it could compete with CaM for the CaM-recognition site on the CaMsensitive enzyme. We used hydrophobic fluorescent probes [32] to obtain information regarding the binding properties of K-252a to CaM; however, K-252a could not be studied because ofits intrinsic fluorescence. Studies of the direct interaction of K-252a with CaM using other techniques will be undertaken. Of the above two explanations, the former appears to be a possibility since preliminary results, obtained using the equilibrium-binding technique on gel filtration, suggest that K-252a clearly binds to CaM (results not shown). For comparison, we examined the effect of K-252a along with the reference CaM antagonists W-7, compound 48/80 and calmidazolium on several CaM-independent systems. In contrast with K-252a, so-called CaM antagonists, under the present assay conditions, did not inhibit the activation of CaM-PDE by limited proteolysis. Our results agree with previous findings reported by Gietzen et al. [9] , but not with those by Itoh & Hidaka [11] . Based on the explanation by Itoh & Hidaka [11] , this discrepancy might be due to differences in the concentration of the substrate.
Unlike so-called CaM antagonists, a significant feature of K-252a is its neutral character. K-252a does not interact with anionic amphiphiles, such as phosphatidylserine and sodium oleate. Although it is uncertain Vol. 256 whether this property of K-252a is related to cellmembrane permeability, K-252a could probably penetrate cell membranes very well. Indeed, K-252a shows the following pharmacological activities in some intact cells or tissues: inhibition of secretory responses in platelets, mast cells and neutrophils [33] [34] [35] ; inhibition ofcontractile response in smooth muscle [36] ; and specific inhibition of the action of nerve growth factor on PC 12 cells [37] and on chick embryo dorsal-root-ganglion cells [38] .
In conclusion, K-252a was shown to be an inhibitor of CaM-PDE in that: (1) unlike so-called CaM antagonists, K-252a is a neutral compound; (2) it does not interact with phosphatidylserine and sodium oleate; (3) it is equally effective at antagonizing all types of activation (CaM or sodium oleate mediated or tryptic digestion), suggesting that it inhibits CaM-PDE phosphodiesterase not only by CaM antagonism but possibly also by interfering directly with the enzyme; and (4) and importantly, in contrast with so-called CaM antagonists, it does not inhibit [3H]nitrendipine binding and CaMindependent Na+ + K+-ATPase.
